What can nose filler change?
The most common use is the bridge. Hyaluronic acid dermal filler placed on the bone and cartilage can raise a low bridge or the root of the nose between the eyes, level a small hump by adding volume above and below it, fill visible dips and even out asymmetry, including after earlier surgery. It can also lift an under-projected or under-rotated tip within limits. An expert consensus for Asian patients covers the bridge, the tip and the columella, the strip of tissue between the nostrils.
The amounts are small, mostly about 1 ml in total, and the changes are measured in millimetres. In a Korean multicentre study of 28 women, across two products, nose height rose by an average of 1.75 millimetres and the root of the nose by 1.24 millimetres at 48 weeks. The effect is visible at once, can be adjusted in steps, and can be dissolved.
What can nose filler not do, and how does it compare with surgery?
Filler only adds. It cannot shorten a long nose, narrow wide nostrils, reduce a large hump or remove bone or cartilage, and a blocked airway needs an ENT assessment first. The skin sets a limit too. At the tip it is thick and tightly bound to the cartilage, so there is little room for more gel. A reference photo of another nose is a request for a different structure, a point made in on wanting to look like someone else.
Surgical rhinoplasty can reshape bone and cartilage, reduce a hump, refine the tip, change the nostrils and improve breathing, and its results last. It is also a larger operation with a high revision rate. Nose filler is the temporary, adjustable option for minor changes in shape, and a systematic review calls it an effective temporary alternative to augmentation rhinoplasty, while noting that complications may be under-reported. When the change wanted is beyond what added volume can do, surgery is the honest route, and an assessment can say so.
How long does nose filler last?
Reviews do not agree on one figure. A literature review of 16 studies found several authors reporting eight to twelve months and others reporting longer, with the longest interval eight years, and its authors called longevity hard to state with certainty. In the Korean study the change had persisted at 48 weeks. The gel is not permanent, and a fair expectation is months to a year or more, varying with the product, the amount and the person.
Why is the nose a higher-risk area?
Two blood supplies meet there. The dorsal nasal artery, a branch of the ophthalmic artery, supplies the upper nose and connects with the angular artery, which comes from the facial artery. That connection is normal anatomy in everyone. If gel enters a small artery of the nose, injection pressure can push it backwards along the vessel towards the ophthalmic artery, and once the pressure stops, the normal flow can carry it on into the eye's own arteries, in rare cases blocking blood to the retina.
Consensus statements name the nose among the higher-risk sites, and one Asian expert panel calls nasal augmentation a high-risk procedure without proper training. In published cases of filler-related vision loss, the nose appears more often than any other injection site, followed by the forehead and the area between the brows. Vision loss from filler is rare, and no rate can honestly be given, because those reports collect the cases that went wrong and not the treatments that went well. Most reported cases did not recover fully, and no treatment has been shown to work consistently.
The skin is at risk too. Filler can block a vessel or press on one from outside, and at the tip that pressure is easier to reach, because thick skin sits tightly on cartilage. The skin can turn pale, then mottled, and, if untreated, blister and break down. Experts report that the skin usually does better when treatment starts within 24 hours. The US FDA's consumer page on dermal fillers, updated in 2023, lists the nose among sites where filler use is not approved, and a review of the practice calls it off-label in the United States. Dermal filler risks in Malaysia sets out how a doctor weighs that.
How do doctors lower the risk, and what should a patient ask?
Every measure lowers the risk, and none removes it. Consensus guidance for the nose asks for a thorough assessment, gel placed deep on the bone or cartilage in small amounts, injected slowly at low pressure, with the direction of injection pointing away from the eye. Expert opinion on cannulas differs, and one consensus adds that a blunt cannula, favoured in some other areas, is not considered a safer choice in the nose.
Preparation counts as much as technique. A doctor should have hyaluronidase, the enzyme that dissolves hyaluronic acid, on hand, know the signs of a blocked vessel and have a plan to act at once, and reviews find that early use of the enzyme is critical in serious complications. Ask three things: is it hyaluronic acid, is the enzyme on hand, and who is holding the syringe. The checks on the doctor, the clinic and the product are the same as for any filler, and the guide to checking an aesthetic doctor covers them. This clinic offers nose filler, and these questions are fair to put to it, as to any clinic.
After treatment, pain out of proportion, skin that turns white, grey or lacy, or blisters means contacting the clinic straight away. Any change in vision or eye pain means the nearest emergency department at once, because for the eye the time available is minutes, not hours.
Can nose filler be dissolved?
Hyaluronic acid filler can be, with the enzyme hyaluronidase. A bridge that is too high or too wide can be softened, and it is the treatment for a blocked vessel in the skin. Dissolving is gradual, and for the skin, the sooner it starts the better. For vision the evidence is thin: no treatment, hyaluronidase included, has been shown to restore sight consistently, and the window is minutes, so the enzyme is not a safety net for the eye. Only hyaluronic acid can be dissolved this way. Silicone and other permanent fillers cannot, they can cause problems years later, and the Ministry of Health's guidelines exclude silicone from the filler procedure.
Who should not have nose filler?
Some people should wait, and some should not have it. Pregnancy and breastfeeding call for deferral, as do an active infection, cold sore or skin inflammation near the injection site, and a known allergy to hyaluronic acid or lidocaine. Previous nose surgery raises the risk: a systematic review of filler in people who had had rhinoplasty observed an increased risk of skin necrosis, and scarring can alter the blood vessels there. Earlier silicone or another permanent filler in the nose calls for a specialist opinion first, because it cannot be dissolved and problems can appear years later. Blood-thinning medicines increase bruising, and a prescribed one must never be stopped without the prescribing doctor. Anyone hoping for a smaller nose, or for a change that adding volume cannot deliver, is better served by an honest no, or by a surgical opinion.
